NCT03325712View on ClinicalTrials.gov

This Study in Healthy Men Tests How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 705564 Affects the Way the Body Breaks Down Midazolam

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 17, 2017

Primary Completion Date

November 26, 2018

Study Completion Date

November 26, 2018

Conditions
Healthy
Interventions
DRUG

BI 705564

Film-coated tablet

DRUG

Placebo

Film-coated tablet

DRUG

Midazolam

Solution for injection

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03325712 - This Study in Healthy Men Tests How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 705564 Affects the Way the Body Breaks Down Midazolam | Biotech Hunter | Biotech Hunter